Recent studies have reported that STATs are associated with tissue fibrosis, including skin, lung, liver, systemic sclerosis (SSc), and STAT3 inhibitors have been shown to be effective in the Carbon tetrachloride (CCl4)-induced liver fibrosis model [17, 18]. The gene discussed is STAT3; the disease is Hepatic fibrosis.